Category: Microbiology & Virology
Global Microbiology & Virology
-
Viral Hepatitis and Retrovirus Diagnostic Tests
... reach US$7.7 Billion by 2030, growing at a CAGR of 8.4% over the analysis period 2024-2030. The U.S. Market is Estimated at US$1.2 Billion While China is Forecast to Grow at 11.3% CAGR The Viral ... Read More
-
Zika Virus Testing
... at a CAGR of 5.8% over the analysis period 2024-2030. Molecular Testing, one of the segments analyzed in the report, is expected to record a 6.4% CAGR and reach US$192.4 Million by the end of ... Read More
-
Chlamydia Infection Diagnostics and Therapeutics
... Billion by 2030, growing at a CAGR of 4.8% over the analysis period 2024-2030. Diagnostics, one of the segments analyzed in the report, is expected to record a 5.1% CAGR and reach US$1.6 Billion by ... Read More
-
Legionella Testing
... CAGR of 8.2% over the analysis period 2024-2030. Culture Methods, one of the segments analyzed in the report, is expected to record a 8.5% CAGR and reach US$122.4 Million by the end of the analysis ... Read More
-
Herpes Marker Testing
... at a CAGR of 4.9% over the analysis period 2024-2030. Antibody / Antigen-Based Kits, one of the segments analyzed in the report, is expected to record a 4.4% CAGR and reach US$332.9 Million by the ... Read More
-
Industrial Microbiology
... CAGR of 4.6% over the analysis period 2024-2030. Pharmaceuticals, one of the segments analyzed in the report, is expected to record a 5.3% CAGR and reach US$11.6 Billion by the end of the analysis period. ... Read More
-
Pneumonia Testing
... CAGR of 6.2% over the analysis period 2024-2030. Immunodiagnostics, one of the segments analyzed in the report, is expected to record a 5.3% CAGR and reach US$339.9 Million by the end of the analysis period. ... Read More
-
Poultry Diagnostics
... CAGR of 9.0% over the analysis period 2024-2030. ELISA, one of the segments analyzed in the report, is expected to record a 9.9% CAGR and reach US$558.3 Million by the end of the analysis period. ... Read More
-
Automated and Rapid Microbiological Tests
... Billion by 2030, growing at a CAGR of 6.7% over the analysis period 2024-2030. GC/CRT (Clinical), one of the segments analyzed in the report, is expected to record a 8.0% CAGR and reach US$1.3 Billion ... Read More
-
Human Papillomavirus (HPV) Testing
... 2030, growing at a CAGR of 6.2% over the analysis period 2024-2030. Hospitals & Clinics, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and reach US$919.4 Million by ... Read More
-
Critical Care Diagnostics
... at a CAGR of 5.9% over the analysis period 2024-2030. Immunoproteins, one of the segments analyzed in the report, is expected to record a 4.8% CAGR and reach US$713.5 Million by the end of the ... Read More
-
Dengue Testing
... CAGR of 4.8% over the analysis period 2024-2030. Hospitals, one of the segments analyzed in the report, is expected to record a 5.8% CAGR and reach US$367.8 Million by the end of the analysis period. ... Read More
-
Sepsis Diagnostics
... CAGR of 7.5% over the analysis period 2024-2030. Microbiology, one of the segments analyzed in the report, is expected to record a 9.1% CAGR and reach US$749.8 Million by the end of the analysis period. ... Read More
-
Cervical Cancer Diagnostic Testing
... 2030, growing at a CAGR of 5.1% over the analysis period 2024-2030. Pap Smear, one of the segments analyzed in the report, is expected to record a 6.1% CAGR and reach US$5.3 Billion by the ... Read More
-
STD Testing
... CAGR of 5.2% over the analysis period 2024-2030. Chlamydia, one of the segments analyzed in the report, is expected to record a 5.0% CAGR and reach US$40.6 Billion by the end of the analysis period. ... Read More
-
Tuberculosis Testing
... CAGR of 4.9% over the analysis period 2024-2030. Hospitals, one of the segments analyzed in the report, is expected to record a 5.3% CAGR and reach US$1.4 Billion by the end of the analysis period. ... Read More
-
Enteric Disease Testing
... at a CAGR of 4.9% over the analysis period 2024-2030. Bacterial Enteric Disease, one of the segments analyzed in the report, is expected to record a 4.8% CAGR and reach US$1.8 Billion by the end ... Read More
-
Clostridium Diagnostics
... CAGR of 14.2% over the analysis period 2024-2030. Immunoassays, one of the segments analyzed in the report, is expected to record a 15.6% CAGR and reach US$9.1 Billion by the end of the analysis period. ... Read More
-
Pneumonia Therapeutics
... CAGR of 6.7% over the analysis period 2024-2030. Drugs, one of the segments analyzed in the report, is expected to record a 2.6% CAGR and reach US$6.8 Billion by the end of the analysis period. ... Read More
-
Cervical Dysplasia Diagnostics
... at a CAGR of 5.9% over the analysis period 2024-2030. Diagnostic Tests, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and reach US$793.8 Million by the end of ... Read More
-
Global Syphilis Testing Market 2025-2029
... provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market scenario, the latest ... Read More
-
2025 Global Forecast for Medical Microbiology Testing Technologies Market (2026-2031 Outlook)-High Tech Outlook Report
... product or service category is within the NAICS Medical Laboratories industry. The product or service category is within the NAICS Medical Laboratories industry. The global market is expected to increase from USD xx billion in ... Read More
-
2025 Medical and Diagnostic Testing Global Market Size & Growth Report with Updated Country Recession Risk Forecasts
... subregions, and 195 countries. Figures are from 2013 through 2024, with forecasts for 2025 and the next 5 years. The historical data utilizes in-depth survey results from companies selling medical and diagnostic testing. The survey ... Read More
-
The Global Influenza Market
... report thoroughly evaluates the market for influenza vaccines, therapeutics and diagnostics. Analyses of the most popular products, clinical trials, new product approvals and emerging technologies are also included in the report. The demographics of the ... Read More
-
Liver Disease Treatment Market Report by Treatment Type (Antiviral Drugs, Immunosuppressants, Vaccines, Immunoglobulins, Corticosteroids, Targeted Therapy, Chemotherapy), Disease Type (Hepatitis, Autoimmune Diseases, Non-alcoholic Fatty Liver Disease (NAFLD), Cancer, Genetic Disorders, and Others), End User (Hospitals, Ambulatory Surgical Centers, and Others), and Region 2025-2033
... 2025-2033. The growing elderly population worldwide, which is prone to several chronic illnesses, including liver disease, is stimulating the market. The liver is a vital organ of the human body that performs significant functions, such ... Read More
Research Assistance
